RAP's management stuffed up 2 clinical trial in the US despite the successful clinical trial here and receiving TGA and CE regulator approval, there was some questionable expenditure with the portable hardware device development and Pfizer end up buying it for 20c after the pps dropped to 4c because of the technology.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.025(9.26%) |
Mkt cap ! $85.10M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 30.0¢ | 27.5¢ | $1.289M | 4.421M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13600 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 40556 | 6 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |